Search Results - "Riddell, Kylie"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial by Ali, Arwa, Dumbrava, Monica, Riddell, Kylie, Stewart, Nina, Ward, Robyn, Ibrahim, Ahmed K, Chin, Melvin

    Published in BMC cancer (22-04-2020)
    “…Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler by Moore, Alison, Riddell, Kylie, Joshi, Shashidhar, Chan, Robert, Mehta, Rashmi

    “…To compare the systemic exposure of salbutamol following delivery from the unit dose dry powder inhaler (UD-DPI) system with that from the Diskus and metered…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate by Mehta, Rashmi, Moore, Alison, Riddell, Kylie, Joshi, Shashidhar, Chan, Robert

    “…The unit dose dry powder inhaler (UD-DPI) is being considered as an alternative inhaler platform that, if developed, has the potential to improve access to…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations by Patel, Aarti, Wilson, Robert, Harrell, Andrew W, Taskar, Kunal S, Taylor, Maxine, Tracey, Helen, Riddell, Kylie, Georgiou, Alex, Cahn, Anthony P, Marotti, Miriam, Hessel, Edith M

    Published in Drug metabolism and disposition (01-04-2020)
    “…In vitro data for low-dose inhaled phosphoinositide 3-kinase delta inhibitor nemiralisib revealed that it was a substrate and a potent metabolism-dependent…”
    Get full text
    Journal Article
  8. 8

    Open-Label, Randomized, 6-Way Crossover, Single-Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination by Ambery, Claire, Riddell, Kylie, Daley-Yates, Peter

    Published in Clinical pharmacology in drug development (01-09-2016)
    “…To investigate the pharmacokinetics of inhaled batefenterol (BAT) and fluticasone furoate (FF) given alone or in combination via ELLIPTA® dry powder inhaler…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler by Mehta, Rashmi, Riddell, Kylie, Gupta, Ashutosh, Louey, Margaret D, Chan, Robert H.

    Published in Clinical drug investigation (01-05-2015)
    “…Background and Objectives The Rotacaps ® /Rotahaler ® system is a single unit dose inhaler being developed to deliver inhaled salmeterol/fluticasone propionate…”
    Get full text
    Journal Article